euro adhoc: Curanum AG / quarterly or semiannual financial statement / Publishing the figures of 2nd Quarter 2008

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

quaterly report

12.08.2008

Ad-hoc-Mitteilung

NET PROFIT CLIMBS BY 18% IN THE FIRTST HALF OF 2008

CURANUM AG, Munich, generated revenue of EUR 63.7 million in the
second quarter of 2008 (previous year: EUR 56.9 million), which
corresponds to an increase of 11.9%. The key factor for the
increase was the first-time consolidation of ELISA Seniorenstift
GmbH, with its six facilities, which was acquired as of January
1, 2008. First-half revenue nevertheless fell short of
our expectations. During the course of the first half of the year,
occupancy fell due to greater competition, with a decline between
February and the end of April to 88%, although it has been
rising again since May. However, this positive trend in the
second quarter was unable to fully compensate for the fall in
utilization.

Earnings before interest, tax, depreciation and amortization (EBITDA)
increased slightly in the second quarter of 2008 from EUR 6.4 million
to EUR 6.8 million. Depreciation and amortization rose from EUR 2.1
million to EUR 2.4 million, and EBIT earnings before interest and
tax grew from EUR 4.3 million to EUR 4.5 million in the second
quarter. After-tax earnings doubled from EUR 0.8 million to EUR
1.7 million when compared with the prior-year reporting
period, primarily due to lower interest payments and a lower tax
rate. Earnings per share correspondingly rose from EUR 0.02 to EUR
0.05 per share.

Net profit rose 18.2% from EUR 3.2 million in the first half of 2007
to EUR 3.8 million. This resulted in earnings per share of EUR 0.12
for the first half of 2008 (previous year: EUR 0.11).

Cash flow from operating activities rose due to the slight
increase in depreciation and amortization, the increase in
provisions, and due to tax rebates of around EUR 2.0 million in
the first half of the year, from EUR 0.8 million in the previous
year to EUR 9.0 million in the reporting period just passed, and
consequently increased tenfold compared with the previous year.
However, cash flow rose in year-on-year comparison even after the
elimination of special effects. For instance, gross cash flow
(excluding changes in provisions and working capital) rose from EUR
8.0 million in the previous year to EUR 11.0 million in the first
half of 2008.

Equity rose as a result of the second-half result to EUR 66.6 million
(December 31, 2007: EUR 62.5 million). This is equivalent to an
equity ratio of 27.1% (December 31, 2007: 26.1%).

CURANUM enjoys a solid starting base for further acquisitions due
to strong growth in cash flow, pleasing growth in equity, and the
accelerated rate of consolidation in the care market, and the
company is confident that it can make these acquisitions in the
second half of 2008. We shall work further on raising quality and
occupancy in the remaining months of the year, and we are assuming
that we shall maintain our current budgeting for the 2008 financial
year.

Munich, August 12, 2008

The Management Board

|Key figures IFRS as of June 30, 2008 | | | | |
| | | | | | | |
| | 2nd | 1st | 1st Quarter|
| |Quarter |Half | |
|mil. EUR |2008 |2007 |2008 |2007 |2008 |2007 |
|Sales |63.7 |56.9 |127.5 |113.5 |63.7 |56.6 |
|Rental costs |13.4 |11.1 |27.2 |22.2 |13.8 |11.1 |
|EBITDA |6.8 |6.4 |14.7 |14.5 |7.9 |8.1 |
|Depreciation |2.4 |2.1 |4.7 |4.2 |2.3 |2.1 |
|EBIT |4.5 |4.3 |10.0 |10.3 |5.5 |6.0 |
|Financial result |-2.3 |-3.0 |-4.8 |-5.0 |-2.5 |-2.0 |
|EBT |2.2 |1.3 |5.3 |5.3 |3.0 |4.0 |
|Net profit |1.7 |0.8 |3.8 |3.2 |2.2 |2.4 |
|Cashflow |4.9 |-2.8 |9.0 |0.8 |4.1 |3.5 |
|Cash and cash equivalents |11.2 |3.5 |11.2 |3.5 |10.0 |4.2 |
|in % of balance sum |27.1% |27.4% |27.1% |27.4% |25.8% |19.3% |
|Balance sheet total |246.0 |226.1 |246.0 |226.1 |250.8 |214.9 |

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Curanum AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Bettina Pöschl

Tel. +49(0)89-242065-69

E-Mail: bettina.poeschl@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: SDAX, CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / regulated dealing